233 related articles for article (PubMed ID: 16540670)
1. Activation of stat3 in human melanoma promotes brain metastasis.
Xie TX; Huang FJ; Aldape KD; Kang SH; Liu M; Gershenwald JE; Xie K; Sawaya R; Huang S
Cancer Res; 2006 Mar; 66(6):3188-96. PubMed ID: 16540670
[TBL] [Abstract][Full Text] [Related]
2. Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression.
Fu XQ; Liu B; Wang YP; Li JK; Zhu PL; Li T; Tse KW; Chou JY; Yin CL; Bai JX; Liu YX; Chen YJ; Yu ZL
Cell Death Dis; 2020 Apr; 11(4):246. PubMed ID: 32312954
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
Zhang ZG; Zhu HM; Hua HK
Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
[TBL] [Abstract][Full Text] [Related]
4. Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes.
Dankner M; Maritan SM; Priego N; Kruck G; Nkili-Meyong A; Nadaf J; Zhuang R; Annis MG; Zuo D; Nowakowski A; Biondini M; Kiepas A; Mourcos C; Le P; Charron F; Inglebert Y; Savage P; Théret L; Guiot MC; McKinney RA; Muller WJ; Park M; Valiente M; Petrecca K; Siegel PM
Neuro Oncol; 2024 Jun; 26(6):1052-1066. PubMed ID: 38271182
[TBL] [Abstract][Full Text] [Related]
5. Pathobiology of brain metastases.
Nathoo N; Chahlavi A; Barnett GH; Toms SA
J Clin Pathol; 2005 Mar; 58(3):237-42. PubMed ID: 15735152
[TBL] [Abstract][Full Text] [Related]
6. Emerging findings into molecular mechanism of brain metastasis.
Ni W; Chen W; Lu Y
Cancer Med; 2018 Aug; 7(8):3820-3833. PubMed ID: 29992751
[TBL] [Abstract][Full Text] [Related]
7. Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.
Berghoff AS; Ilhan-Mutlu A; Dinhof C; Magerle M; Hackl M; Widhalm G; Hainfellner JA; Dieckmann K; Pichler J; Hutterer M; Melchardt T; Bartsch R; Zielinski CC; Birner P; Preusser M
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e41-55. PubMed ID: 25256708
[TBL] [Abstract][Full Text] [Related]
8. Vascular mimicry as a facilitator of melanoma brain metastasis.
Provance OK; Oria VO; Tran TT; Caulfield JI; Zito CR; Aguirre-Ducler A; Schalper KA; Kluger HM; Jilaveanu LB
Cell Mol Life Sci; 2024 Apr; 81(1):188. PubMed ID: 38635031
[TBL] [Abstract][Full Text] [Related]
9. MET receptor serves as a promising target in melanoma brain metastases.
Redmer T; Schumann E; Peters K; Weidemeier ME; Nowak S; Schroeder HWS; Vidal A; Radbruch H; Lehmann A; Kreuzer-Redmer S; Jürchott K; Radke J
Acta Neuropathol; 2024 Feb; 147(1):44. PubMed ID: 38386085
[TBL] [Abstract][Full Text] [Related]
10. Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective.
Jill N; Bhootra S; Kannanthodi S; Shanmugam G; Rakshit S; Rajak R; Thakkar V; Sarkar K
Clin Exp Med; 2023 Dec; 23(8):4323-4339. PubMed ID: 37775649
[TBL] [Abstract][Full Text] [Related]
11. Asiatic Acid Inhibits Nasopharyngeal Carcinoma Cell Viability and Migration via Suppressing STAT3 and Claudin-1.
Pantia S; Kangsamaksin T; Janvilisri T; Komyod W
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375849
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-like protein FAT10 in hepatocellular carcinoma cells limits the efficacy of anti-VEGF therapy.
Qiu Y; Che B; Zhang W; Zhang AV; Ge J; Du D; Li J; Peng X; Shao J
J Adv Res; 2024 May; 59():97-109. PubMed ID: 37328057
[TBL] [Abstract][Full Text] [Related]
13. Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer.
Alsabbagh R; Ahmed M; Alqudah MAY; Hamoudi R; Harati R
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190188
[TBL] [Abstract][Full Text] [Related]
14. Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.
Tran TT; Caulfield J; Zhang L; Schoenfeld D; Djureinovic D; Chiang VL; Oria V; Weiss SA; Olino K; Jilaveanu LB; Kluger HM
JCI Insight; 2023 Apr; 8(7):. PubMed ID: 36821392
[TBL] [Abstract][Full Text] [Related]
15. An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Bassey-Archibong BI; Rajendra Chokshi C; Aghaei N; Kieliszek AM; Tatari N; McKenna D; Singh M; Kalpana Subapanditha M; Parmar A; Mobilio D; Savage N; Lam F; Tokar T; Provias J; Lu Y; Chafe SC; Swanton C; Hynds RE; Venugopal C; Singh SK
Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2205247120. PubMed ID: 36780531
[TBL] [Abstract][Full Text] [Related]
16. Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases.
Wei AZ; Uriel M; Porcu A; Manos MP; Mercurio AC; Caplan MM; Hulse L; Seedor RS; Holovatska M; Francis J; Khan SA; McDonnell DE; Bogomolny D; Sato T; Marr BP; Haq R; Orloff M; Shoushtari A; Carvajal RD
Front Oncol; 2022; 12():961517. PubMed ID: 36212499
[TBL] [Abstract][Full Text] [Related]
17. CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells.
Reigstad A; Herdlevær CF; Rigg E; Hoang T; Bjørnstad OV; Aasen SN; Preis J; Haan C; Sundstrøm T; Thorsen F
PLoS One; 2022; 17(9):e0273711. PubMed ID: 36084109
[TBL] [Abstract][Full Text] [Related]
18. A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
Stejerean-Todoran I; Gimotty PA; Watters A; Brafford P; Krepler C; Godok T; Li H; Bonilla Del Rio Z; Zieseniss A; Katschinski DM; Sertel SM; Rizzoli SO; Garman B; Nathanson KL; Xu X; Chen Q; Oswald JH; Lotem M; Mills GB; Davies MA; Schön MP; Bogeski I; Herlyn M; Vultur A
Neuro Oncol; 2023 Apr; 25(4):674-686. PubMed ID: 36054930
[TBL] [Abstract][Full Text] [Related]
19. Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway.
Jie Z; Wang S; Ma Q; Shen Y; Zhao X; Yu H; Xie Z; Jiang C
J Bone Oncol; 2022 Aug; 35():100439. PubMed ID: 35800294
[TBL] [Abstract][Full Text] [Related]
20. Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis.
Carretero-González A; Hergueta-Redondo M; Sánchez-Redondo S; Ximénez-Embún P; Manso Sánchez L; Gil EC; Castellano D; de Velasco G; Peinado H
Oncoimmunology; 2022; 11(1):2067944. PubMed ID: 35481283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
